Overall rank by patents
#40,628
of 49,997 tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Hanmi Pharmaceutical Co., Ltd.
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Hanmi ranks #40,628 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.
- #40,628
- of 49,997 US assignees by volume
- 24th percentile
- by Innovation Score (27.7/100)
- 14.3
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R40628 · Foreign Corporation #40,628 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #40,628/49,997
- PHOTO-FINISH Hangzhou Santan…
- CPC-NARROW A61P · 5 areas
- INNOV-THIN 27.7/100
- CLAIMS-RICH 14.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Hangzhou Santan Medical Technology Co., Ltd (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Innovation-score neighbourhood around Hanmi
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- I D YOU · near 28
I D YOU · near
28 score
- Hanmi Pharmaceutical · this assignee 28
Hanmi Pharmaceutical · this assignee
28 score
- Mueller Sports… · near 28
Mueller Sports… · near
28 score
- Ortho Development · near 28
Ortho Development · near
28 score
- Crystal Group · near 28
Crystal Group · near
28 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Hanmi's Innovation Score is 27.7/100 (24th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Where Hanmi's grants concentrate
Hanmi Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2021. By volume, Hanmi sits between Hangzhou Santan Medical Technology Co., Ltd and Haskoningdhv Nederland B.V..
Hanmi's three-year grant acceleration
Hanmi Pharmaceutical Co., Ltd. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Hanmi's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Hangzhou Santan M…
Hangzhou Santan Medical Technology Co., Ltd
6 patents
- Hangzhou Sicco Ar…
Hangzhou Sicco Art-technology Co., Ltd
6 patents
- Hangzhou Yiyuqian…
Hangzhou Yiyuqianxiang Technology Co., Ltd.
6 patents
- Hanil E-hwa
Hanil E-hwa Co., Ltd.
6 patents
- Hanvon Ugee Techn…
Hanvon Ugee Technology Co., Ltd.
6 patents
- Harman Internatio…
Harman International (CHINA) Holdings Co., Ltd.
6 patents
- Harwin
Harwin PLC
6 patents
- Haskoningdhv Nede…
Haskoningdhv Nederland B.V.
6 patents
- Hanmi Pharmaceuti… ◀
Hanmi Pharmaceutical Co., Ltd.
6 patents
What this shows Hanmi holds 6 patents at rank #40,605, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Hanmi
By rank, the assignees closest to #40,605 in granted patent volume.
- Hangzhou Santan Medical Technology Co., Ltd #40,601 · 6 patents
- Hangzhou Sicco Art-technology Co., Ltd #40,602 · 6 patents
- Hangzhou Yiyuqianxiang Technology Co., Ltd. #40,603 · 6 patents
- Hanil E-hwa Co., Ltd. #40,604 · 6 patents
- Hanvon Ugee Technology Co., Ltd. #40,606 · 6 patents
- Harman International (CHINA) Holdings Co., Ltd. #40,607 · 6 patents
- Harwin PLC #40,608 · 6 patents
- Haskoningdhv Nederland B.V. #40,609 · 6 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Hanmi's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Hanmi, neither rank-band nor same-CPC leaders (those blocks stay above).
Similar innovation score
Nearest assignees by Innovation Score (28 here).
Hanmi's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 24th percentile higher than 24% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 33.3% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
| 2025partial year | 1 | 16.7% |
Which technologies does Hanmi Pharmaceutical Co., Ltd. patent most?
Top 5 of 5 technology areas
What to do with this data
Hanmi Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.
- Hanmi Pharmaceutical Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #40,628 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Hanmi Pharmaceutical Co., Ltd. against Hangzhou Santan Medical Technology Co., Ltd, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 27.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.